Birthweight Extremes and Neonatal and Childhood Outcomes after Preterm Premature Rupture of Membranes by Grace, M.R. et al.
Birthweight Extremes and Neonatal and
Childhood Outcomes after Preterm Premature
Rupture of Membranes
Matthew R. Grace, MD1 Sarah Dotters-Katz, MD2 Michael W. Varner, MD2 Kim Boggess, MD1
Tracy A. Manuck, MD1,2
1Division of Maternal Fetal Medicine, Department of Obstetrics and
Gynecology, University of North Carolina School of Medicine,
Chapel Hill, North Carolina
2Division of Maternal Fetal Medicine, Department of Obstetrics and
Gynecology, University of Utah, Salt Lake City, Utah
Am J Perinatol 2016;33:1138–1144.
Address for correspondence Matthew R. Grace, MD, Division of
Maternal Fetal Medicine, Department of Obstetrics and Gynecology,
University of North Carolina School of Medicine, 3010 Old Clinic
Building, CB#7516, Chapel Hill, NC 27599-7516
(e-mail: matthew_grace@med.unc.edu).
Preterm premature rupture of membranes (PPROM) is the
leading identifiable cause of pretermbirth and affects 3% of all
pregnancies.1 Following PPROM, women are at high risk of
additional pregnancy complications including preterm labor,
placental abruption, and chorioamnionitis.2,3 Women with
PPROM between 23 and 34 weeks of gestation and without
evidence of other immediate complications are typically
administered a course of antenatal corticosteroids, intrave-
nous magnesium sulfate for neuroprotection (up to 32 wk),
and latency antibiotics, and are hospitalized until delivery.4–6
Premature infants, including those born after PPROM, are
at risk of both short-term and long-termmorbidity and death.
Long-term complications of prematurity persist into child-
hood and beyond, and may include neurodevelopmental
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Abstract Objective To determine the association between birthweight extremes and risk of
adverse neonatal and childhood outcomes following preterm premature rupture of
membranes (PPROM).
Study Design This is a secondary analysis of data from the Beneficial Effects of
Antenatal Magnesium Sulfate Trial. Women with nonanomalous singletons and PPROM
delivering 24.0 weeks were included. Birthweight was classified as small for gesta-
tional age (SGA), appropriate for gestational age (AGA), or large for gestational age
(LGA). Composite severe neonatal morbidity and childhood outcomes at age 2, were
compared between these groups.
Results One thousand five hundred and ninety-eight infants were included (58 SGA,
1,354 AGA, and 186 LGA). There was an inverse relationship between birthweight and
rate of compositemajor neonatal morbidity (55.2% of SGA, 31.5% of AGA, 18.3% of LGA,
p < 0.001). Former-SGA children were more likely to be diagnosed with major
composite childhood morbidity at age 2 (25.9% of SGA, 8.3% of AGA, 5.9% of LGA,
p < 0.001). In multivariate models, LGA infants had improved initial neonatal outcomes
compared with AGA infants (adjusted odds ratio [aOR], 0.44; 95% confidence interval
[CI], 0.28–0.71; p ¼ 0.001).
Conclusion Among infants delivered following PPROM, those who were LGA at
delivery had improved composite adverse neonatal outcomes. SGA increases the risk
of severe neonatal morbidity, early childhood death, and moderate/severe cerebral
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disabilities, failure-to-thrive, vision and hearing impairment,
and cerebral palsy (CP).7,8 Although gestational age at birth is
typically regarded as the most important factor influencing
the risk of both short- and long-term morbidity, other risk
factors are known to affect outcomes, including birthweight,
gender, and medication exposure (e.g., antenatal corticoste-
roids, magnesium sulfate) prior to delivery.8,9 Birthweight
estimates are often used along with gestational age to counsel
families regarding infant outcome following preterm delivery
and in decisions regarding antenatal testing and intervention,
mode of delivery, and postnatal intervention.10,11 The corre-
lation between ultrasound (US)-based estimates of fetal
weight in the setting of PPROM and postnatal birthweight
is understudied, and is likely hindered by the high incidence
of oligohydramnios and anhydramnios in this population.
The extent to which extremes of birthweight (e.g., being
large for gestational age [LGA] or small for gestational age
[SGA] compared with birthweight that is appropriate for
gestational age [AGA]) affect postnatal outcomes among
infants born after PPROM is unknown.We sought to determine
the relationship between birthweight extremes (LGA, SGA)
and major neonatal and childhood morbidity. We hypothe-
sized that compared with AGA infants delivered after PPROM,
LGA infants have lower prevalence of adverse neonatal and
childhood outcomes and that SGA infants have higher inci-
dence of adverse neonatal and childhood outcomes.
Materials and Methods
This is a secondary analysis of a multicenter, randomized
clinical trial of antenatal magnesium sulfate versus placebo
administered to women at imminent risk for early preterm
birth (<32 wk) to prevent death and CP in their offspring. The
inclusion criteria and randomization protocol for the original
trial have been previously reported.12 Briefly, the original
study recruitedwomen from 1997 to 2004 at 20 centers, who
were at high risk of preterm delivery between 24 to 31weeks’
gestation for any indication. The majority of enrolled women
had pregnancies complicated by PPROM. Per the original
protocol, study staff evaluated surviving infants at 6, 12,
and 24 months corrected gestational age. Written, informed
consent was obtained at the time of the original study from
each participant. This secondary analysis used a de-identified
dataset, and after review by our Institutional Review Board
(IRB) at the University of North Carolina, was considered
exempt from IRB oversight.
For the purposes of this secondary analysis, we included
women with singleton, nonanomalous gestations with a
diagnosis of PPROM who delivered at 24 weeks 0 days
through 34 weeks and 6 weeks. Gestational age was deter-
mined from standard algorithms using last menstrual period
and US criteria.13 Neonatal birthweight was classified as AGA
(10–90 percentile), LGA (90percentile), or SGA (<10percen-
tile) based upon gender- and gestational age-specific contem-
porary national norms.14 The primary neonatal outcomewas
a composite of severe neonatal morbidity, defined as one or
more of the following; neonatal sepsis, grade III or IV intra-
ventricular hemorrhage, periventricular leukomalacia, severe
(stage II or III) necrotizing enterocolitis, bronchopulmonary
dysplasia (BPD), and/or death during the initial hospitaliza-
tion. The primary childhood outcome was a composite of
stillbirth or infant death by 1 year of age, or moderate or
severe CP, as assessed at the final follow-up visit, prespecified
to occur at 2 years of age. Secondary outcomes included
individual components of each of the two primary composite
outcomes and Bayley Scales of Infant Development II Mental
Development Index (MDI) and/or Psychomotor Development
Index (PDI) greater than 2 standard deviation (SD) below the
mean at age 2. We also compared weight at the time of
childhood follow-up assessments to determine whether for-
merly-SGA infants remained smaller than their formerly-AGA
and formerly-LGA counterparts in early childhood.
Bivariate analyses were by chi-square or Fisher’s exact for
categorical variables, analysis of variance or Kruskal–Wallis
equality of proportions rank test when there were greater
than two categories. The Wilcoxon-type test for trend as
described by Cuzick was utilized to assess trend across
ordered groups.15 Multivariable analysis was performed us-
ing stepwise backward elimination logistic regression, and
factors with p < 0.20 remained in final models. All data were
analyzed using STATAversion 13.1 (College Station, TX). In the
final bivariate and multivariable analyses a p-value of < 0.05
was considered significant.
Results
From the original cohort of 2,241 women, 1,598 women and
their infants met inclusion criteria (►Fig. 1). Of these, 58
(3.6%) were SGA, 1,354 (84.7%) were AGA, and 186 (11.6%)
were LGA. Demographic characteristics are compared by
birthweight group in ►Table 1. Groups were different with
regard to likelihood of diabetes mellitus diagnosis and pre-
pregnancy body mass index (►Table 1).
►Table 2 shows the pregnancy characteristics of our study
cohort. Overall, 494 women (30.9%) had a first trimester US
(<14 week-gestation), which did not vary by birthweight
group (►Table 2). Other pregnancy dating criteria, were also
similar between groups (►Table 2). Womenwith SGA infants
had PPROM, and subsequent delivery at earlier gestational
ages than women with AGA and LGA infants; they were also
more likely to deliver by cesarean and require a cesarean
delivery for fetal intolerance of labor (►Table 2).
In bivariate analyses, there was an inverse relationship
between neonatal outcomes and birthweight group
(►Table 3). SGA infants had a higher prevalence of composite
major neonatal morbidity compared with AGA and LGA infants
(55.2% vs 31.5% vs 18.3%, respectively,p < 0.001). This effectwas
driven by several components of the composite outcome (death
prior to initial hospital discharge, BPD, and neonatal sepsis).
Former-SGA childrenwere alsomore likely to be diagnosedwith
major composite childhood morbidity at age 2 compared with
former-AGA and former-LGA children (25.9% vs 8.3% vs 5.9%,
respectively, p < 0.001), (►Table 3). Surviving former-SGA chil-
dren were also more likely than former-AGA or former-LGA
children to haveBayley IIMDI scoresgreater than 2 SDbelow the
mean (24.4% vs 16.9% vs 10.3%, respectively, p ¼ 0.043).
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In multivariable models, several factors remained associ-
ated with major neonatal morbidity (►Table 4). After con-
trolling for delivery gestational age, compared with AGA
infants, LGA infants were less likely (aOR, 0.44; 95% CI,
0.28–0.71; p ¼ 0.001), and SGA infants were more likely,
(aOR, 2.11; 95% CI, 0.98–4.56; p ¼ 0.057) to have a composite
adverse outcome. However, former-SGA infants were more
likely to develop major childhood morbidity at age 2 (aOR,
2.63; 95% CI, 1.27–5.45; p ¼ 0.009), compared with AGA
infants, whereas those former-LGA infants had similar risk
Fig. 1 Study enrollment. GA, gestational age; PPROM, preterm premature rupture of membranes.There were 203 twin pregnancies.











Maternal age (y; median, IQR) 25.5 (22–31) 26 (21–30) 27 (22–32) 0.023










African-American 36 (62.1) 612 (45.2) 77 (41.4) 0.302
Caucasian 15 (25.9) 499 (36.8) 74 (39.8)
Hispanic 6 (10.3) 211 (15.6) 31 (16.7)
Married (n; %) 26 (44.8) 635 (47.0) 101 (54.3) 0.160
High school education or higher (n; %) 35 (61.4) 865 (63.9) 130 (69.9) 0.248
Alcohol use during pregnancy (n; %) 6 (10.3) 130 (9.6) 18 (9.7) 0.982
Tobacco use during pregnancy (n; %) 15 (25.9) 411 (30.3) 48 (25.8) 0.364
Drug use during pregnancy (n; %) 4 (6.9) 154 (11.4) 18 (9.7) 0.469
Nulliparous (n; %) 25 (43.1) 471 (34.8) 62 (33.3) 0.381
Diabetes (n; %)
Pregestational 1 (1.7) 19 (1.4) 4 (2.2) 0.550
Gestational 3 (5.2) 39 (2.9) 12 (6.5) 0.030
Any 4 (6.9) 58 (4.3) 16 (8.6) 0.027
Previous preterm birth (n; %) 14 (24.1) 391 (28.9) 48 (25.8) 0.530
Abbreviation: IQR, interquartile range.
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comparedwith former-AGA children (aOR, 0.74; 95% CI, 0.35–
1.55; p ¼ 0.425), ►Table 5. Male gender was associated with
worse outcomes both during the initial neonatal period and at
age 2 (►Tables 4 and 5).
Finally, we compared themedian birthweight in kilograms
(kg) and at each childhood follow-up visit, stratified by
birthweight group. Children’s weights were recorded at the
three prespecified follow-up visits and the timing of the
follow-up visits did not vary by birthweight group (median
of 6, 13 and 25mo), corrected for prematurity. At each follow-
up visit, the former-SGA children remained significantly
lighter than their former-AGA counterparts, who in turn
were significantly lighter than the former-LGA children
(p < 0.001 for all time points studied, ►Fig. 2).
Comment
In this large, prospectively collected cohort of women with
pregnancies complicated by PPROM, we found that infant
birthweight classification is associated with both adverse
initial neonatal outcomes and adverse childhood neurodeve-
lopmental outcomes at age 2. These differences appeared
most significant for those SGA at delivery, as adverse out-
comes persisted to early childhood. The apparent advantage
conferred shortly after birth to LGA infants appeared to be
short-lived, as neurodevelopmental outcomes were similar
between former-LGA and former-AGA children when they
were evaluated at age 2.
These findings are consistent with limited previous re-
ports examining the effect of birthweight on preterm mor-
bidity and mortality, particularly among neonates with an
antenatal diagnosis of intrauterine fetal growth restriction.
Multiple prior studies have demonstrated adverse effects of
intrauterine fetal growth restriction (diagnosed antenatally)
on initial childhood outcomes as well as neurodevelopmental
impairment.16–18However, the majority of prior studies have
focused specifically on antenatal growth restriction and US
parameters, and have used this information for decision
making.19,20 This cohort, where PPROM was the obstetric
diagnosis for all women studied, likely represents a different
population, given different underlying pathophysiology con-
tributing to premature membrane rupture, and provides
valuable information regarding anticipated postnatal out-
comes among babies delivered following this complication.
Furthermore, we report information on infants that were
LGA at delivery. Although these infants experienced lower
morbidity in the neonatal period, this benefit was transient,
as they experienced similar neurodevelopmental outcomes at
age 2 to former-AGA children. We hypothesize that LGA
infants might have improved outcomes due to reduced
need for transfusion, and also reduced temperature instabili-
ty, known risk factors for neonatal morbidity.21,22 Unfortu-
nately, our study design does not permit us to answer these
mechanistic questions directly. For all groups, size at birth
was highly correlated with weight across multiple follow-up
visits through 2 years of age. The longer term (e.g., adult)












Mean gestational age at first ultrasound (wk;  SD) 18.8  6.8 18.2  7.2 18.8  8.6 0.537
First ultrasound was prior to 14 wk gestation (n; %) 15 (25.9) 414 (30.6) 65 (35.0) 0.336
Patient had a missing last menstrual period date (n; %) 5 (8.6) 122 (9.0) 20 (10.8) 0.734
Patient reported a “sure” last menstrual period date (n; %) 36 (62.1) 792 (58.5) 107 (57.5) 0.828
Mean gestational age at PPROM (wk;  SD) 26.9  3.1 28.0  2.5 28.4  2.4 0.005
Randomized to receive magnesium sulfate (n; %) 29 (50) 670 (49.5) 80 (43.0) 0.253
Received antenatal antibiotics (n; %) 58 (100) 1,308 (96.6) 180 (96.8) 0.361
Received antenatal corticosteroids (n; %) 57 (98.3) 1,322 (97.6) 181 (97.3) 0.912
Latency between PPROM and delivery (d; median, IQR) 6.4 (3.8–13.1) 6.9 (3.3–14.1) 6.6 (2.6–15.1) 0.915
Chorioamnionitis (n; %) 8 (13.8) 174 (12.9) 26 (14.0) 0.898
Preeclampsia (n; %) 1 (1.7) 8 (0.6) 1 (0.5) 0.386
Meconium stained amniotic fluid (n; %) 3 (5.2) 31 (2.3) 3 (1.6) 0.261
Cesarean delivery (n; %) 31 (53.5) 510 (37.7) 56 (30.1) 0.005
Cesarean delivery for fetal intolerance of labor (n; %) 14/31 (45.2) 218/510 (42.8) 14/56 (25) 0.034
Cesarean delivery for malpresentation (n; %) 17/31 (54.8) 251/510 (49.2) 31/56 (55.4) 0.589
Mean gestational age at delivery (wk;  SD) 28.3  3.1 29.5  2.6 29.9  2.4 0.004
Abbreviations: IQR, interquartile range; PPROM, preterm premature rupture of membranes; SD, standard deviation.
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implications of LGA and SGA birthweight for gestational age
growth patterns is unknown.
In this population, traditional risk factors for aberrant fetal
growth were uncommon; for example, use of tobacco and
illicit drugs was low and did not vary by birthweight group.
Pre-eclampsia was also uncommon. Previous studies exam-
ining the rate of fetal growth following PPROM or after the
onset of spontaneous preterm labor have noted reduced
growth velocity, suggesting that slowing of fetal growth
may participate in the mechanism of preterm labor.23,24
Significant placental lesions (e.g., syncytiotrophoblast knot-
ting, villous fibrosis, avascular terminal villi, accelerated
villous maturation) have been associated with abnormal fetal
growth in the setting of preterm delivery, supporting the
theory that the development of these complications may be a
chronic process.25,26
Our finding of a greater proportion (11.6%) of LGA com-
paredwith SGA infants (3.6%) is of uncertain significance, and
warrants further investigation in other cohorts. The rate of
SGA is uncommonly reported following PPROM, but the
incidence in our population was similar to that reported in
a large cohort (n ¼ 4,102) of women delivering <32 weeks,











Male fetus (n; %) 35 (60.3) 726 (53.6) 90 (48.4) 0.222
Median birthweight (kg; IQR) 0.73 (0.57–1.13) 1.35 (0.99–1.67) 1.79 (1.35–2.10) <0.001
5-min Apgar score < 7 (n; %) 17 (29.3) 252 (18.6) 25 (13.5) 0.023
Birth head circumference < 10% for
gestational age (n; %)
31 (56.4) 96 (7.2) 1 (0.6) <0.001
Birth length < 10% for gestational age (n; %) 27 (47.4) 65 (4.8) 1 (0.6) <0.001
Composite major neonatal morbidity (n; %) 32 (55.2) 426 (31.5) 34 (18.3) <0.001
Death prior to initial hospital discharge (n; %) 10 (17.9) 63 (4.7) 4 (2.2) <0.001
Necrotizing enterocolitis, stage II or III (n; %) 0 (0) 66 (4.9) 4 (2.2) 0.055
Bronchopulmonary dysplasia (n; %) 17 (30.4) 233 (17.3) 15 (8.2) <0.001
Confirmed neonatal sepsis (n; %) 14 (25.0) 222 (16.5) 15 (8.2) 0.002
Intraventricular hemorrhage, grade III or IV (n; %) 1 (1.9) 21 (1.6) 3 (1.7) 0.981
Periventricular leukomalacia (n; %) 1 (1.9) 21 (1.6) 3 (1.7) 0.981
Composite major childhood morbidity (n; %) 15 (25.9) 112 (8.3) 11 (5.9) <0.001
Stillbirth or infant death (n; %) 14 (24.6) 92 (7.1) 8 (4.4) <0.001
Moderate or severe cerebral palsy at age 2a 1/43 (1.8) 21/1,201 (1.6) 3/172 (1.7) 0.790
Bayley MDI score > 2 SD below the meana 10/41 (24.4) 185/1,096 (16.9) 16/155 (10.3) 0.043
Bayley PDI score > 2 SD below the meana 4/41 (9.8) 166/1,102 (15.1) 19/157 (12.1) 0.417
Abbreviations: IQR, interquartile range; MDI, mental development index; PDI, psychomotor development index; SD, standard deviation.
aAmong the 43 small for gestational age, 1,201 appropriate for gestational age, and 172 large for gestational age children surviving to age 2. Not all
assessments were completed for each child; numerator for each parameter reflects number of living children with available data.
Table 4 Multivariate logistic regression model for major neonatal morbidity
Characteristic OR 95% CI p-value
Delivery gestational age (per 1 wk interval) 0.50 0.47–0.54 <0.001
Male infant 1.52 1.15–2.00 0.003
Maternal education (per y completed) 1.05 0.99–1.11 0.073
Infant size at delivery
Small for gestational age 2.11 0.98–4.56 0.057
Appropriate for gestational age 1.00 Ref Ref
Large for gestational age 0.44 0.28–0.71 0.001
Abbreviations: CI, confidence interval; OR, odds ratio; Ref, reference group.
Note: Other factors considered in initial model but removed from final models due to p > 0.20 included maternal body mass index, randomization to
magnesium sulfate, maternal smoking, and maternal diabetes mellitus.
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where 4.7% delivered after PPROM were SGA.27 A phenotype
of rapid fetal growth prior to the occurrence of late preterm
birth has been described; we speculate that perhaps this may
have contributed to the lower rate of SGA and the higher rate
of LGA even though this cohort was primarily earlier pre-
term.28 Further mechanistic investigations are needed, and
placental pathology information will be crucial to unraveling
underlying etiologies of growth disturbances in these fetuses.
Our study has several strengths. This is a large, well-defined
cohort of women with PPROM, diagnosed in a standardized
fashion. Given that the original study was not focused on fetal
growth per se, women were not excluded due to suspected
normal or abnormal fetal growth, and we had the distinct
advantage of being able to evaluate the impact of SGA and LGA
from within the same cohort. Neonatal and childhood out-
comes were also standardized and were rigorously prospec-
tively assessed by trained research staff. We had detailed
pregnancy dating information available, reducing the likeli-
hood that infants were misclassified as SGA or LGA due to
incorrect pregnancy dating. Furthermore, incorporation of
early childhood outcomes at age 2 allowed for more compre-
hensive assessment regarding the impact of size on outcomes.
Our analysis is not without limitation. As with all second-
ary analyses, we were limited to the data previously collected
as part of the main trial. We did not have information
regarding placental pathology, and had minimal details re-
garding US assessments following PPROM. We also had very
limited data regarding estimated fetal weight or amniotic
fluid index (AFI) by US following PPROM, and therefore, are
unable to examine outcomes based on individual biometric
parameters (e.g., abdominal circumference or AFI) or evaluate
howvarious Doppler indicesmay impact outcomes. The study
design did not permit us to examine themechanism bywhich
SGA contributes to adverse outcomes. Additionally, we were
limited by the relatively small number of infants with SGA.
In conclusion, among infants delivered following PPROM,
neonatal outcomes were inversely related to size at delivery,
with fewer LGA infants experiencing early morbidity compared
with AGA and SGA infants. At age 2, former-SGA children had
continued adverse effects, with significantly worse neurodeve-
lopmental outcomes compared with former-AGA and former-
LGA children. However, the apparent benefit of LGA that was
seen during the neonatal period was no longer appreciated in
early childhood. These data have implications for counseling
patients; future studies should confirm these results and inves-
tigate potential mechanisms behind these findings.
Note
This study was presented, in part, in poster format at the
34th annual meeting of the Society for Maternal-Fetal
Medicine, New Orleans, LA, February 3 to 8, 2014.
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Table 5 Multivariate logistic regression model for major
childhood morbidity at age 2
Characteristic OR 95% CI p-value
Male child 1.63 1.08–2.47 0.021
Delivery gestational age




(per 1 unit increase)
1.02 0.99–1.05 0.150
Infant size at delivery




Large for gestational age 0.74 0.35–1.55 0.425
Abbreviations: CI, confidence interval; OR, odds ratio; Ref, reference group.
Note: Other factors considered in initialmodel but removed from finalmodels
due to p > 0.20 included randomization to magnesium sulfate, maternal
education level, maternal smoking, and maternal diabetes mellitus.
Fig. 2 Medianweight at birth and at subsequent follow-up visits, stratifiedby
birthweight group. Error bars represent interquartile range. Ages listed for
follow-up visits were at corrected gestational ages. Timing of visits did not
differ by birthweight group. Follow-up weight examination at visit 1 included
44 formerly-SGA, 1,219 formerly- AGA, and 174 formerly- LGA, at visit 2
included 40 formerly-SGA, 1,130 formerly-AGA, and 167 formerly-LGA, and at
visit 3 included 34 formerly-SGA, 847 formerly-AGA, and 120 formerly-LGA
children. AGA, appropriate for gestational age; LGA, large for gestational age;
SGA, small for gestational age. p < 0.001 for each visit.
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